Deterioration of the protein kinase C-KATP channel pathway in regulation of coronary flow in hypercholesterolaemic rabbits

Eva Pongo, Zsolt Balla, Kanigula Mubagwa, Willem Flameng, Istvan Edes, Zoltan Szilvassy, Peter Ferdinandy

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We studied the effect of experimental hypercholesterolaemia/atherosclerosis on changes in coronary flow and cardiac function, induced by protein kinase C and ATP-sensitive K+ (KATP) channel modulators in isolated Langendorff-perfused rabbit hearts. Both phorbol 12-myristate-13-acetate (PMA) and phorbol 12,13-dibutyrate (PDB, 0.1 μM each), activators of protein kinase C, decreased, whereas staurosporine, (0.1 μM), a protein kinase C inhibitor, increased coronary flow and left ventricular dP/dt, an index of ventricular contractility. Glyburide (5-50 μM), a KATP channel inhibitor, blocked the effect of staurosporine. The phorbol esters were without effect in the presence of pinacidil (5 μM), a KATP channel activator. Neither the protein kinase C modulators nor glyburide produced any effect on coronary flow and left ventricular contractility, when the hearts were prepared from animals either maintained on a cholesterol (1.5%)-enriched diet or treated with lovastatin (5 mg/kg/day per os). Treatment with farnesol (1 mg/kg twice a day for 7 days intravenously) restored the reactivity of hearts from either hypercholesterolaemic or lovastatin-treated animals to protein kinase C modulators. We conclude that non-cholesterol mevalonate products are necessary for the functional integrity of the protein kinase C-KATP channel pathway in the rabbit heart.

Original languageEnglish
Pages (from-to)217-223
Number of pages7
JournalEuropean Journal of Pharmacology
Volume418
Issue number3
DOIs
Publication statusPublished - Apr 27 2001

    Fingerprint

Keywords

  • Farnesol
  • Heart
  • Hypercholesterolaemia
  • K channel
  • Protein kinase C
  • Rabbit

ASJC Scopus subject areas

  • Pharmacology

Cite this